“First Generics” Will Get Expedited ANDA Reviews Under New FDA Policy

FDA's "First Generics" policy sets a priority review goal of six months for ANDAs for which there is no marketed generic equivalent

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet